Faculty Articles
Patient Satisfaction with Extended-Interval Warfarin Monitoring
Publication Title
Journal of Thrombosis and Thrombolysis
Publisher
Kluwer Academic Publishers
Publication Date
11-1-2016
Keywords
aged, drug monitoring, female, humans, male, middle aged, patient satisfaction, pilot projects, prospective studies, warfarin
Abstract
Extended-interval monitoring of warfarin has been proposed to reduce follow-up burden and improve patient satisfaction. We aimed to make an initial assessment of anticoagulation satisfaction before and after an extended-interval warfarin monitoring intervention. We conducted a translational prospective single-arm pilot study of extended-interval warfarin monitoring in five pharmacist-managed anticoagulation clinics. Patients meeting CHEST guideline criteria for extended-interval warfarin monitoring began progressive extended-interval follow-up (6, 8, and 12 weeks thereafter). The Duke Anticoagulation Satisfaction Scale (DASS) was administered at baseline and at end-of-study or study removal (in patients no longer appropriate for extended interval follow-up). Forty-six patients had evaluable pre- and post-intervention DASS survey data. Mean age of patients was 66.5 years, 74 % were non-Hispanic whites, and 48 % were men. Patients completed a mean ± SD of 34 ± 22 weeks of follow-up. Mean ± SD total DASS score at baseline was 45.2 ± 14.2 versus 49.1 ± 14.9 at end-of-study (mean change, +3.9 [95 % CI -0.6-8.4; p = 0.09]), indicating no benefit-and trending toward decrement-to anticoagulation satisfaction. Change in anticoagulation satisfaction varied substantially following extended-interval monitoring, with no evidence of improved satisfaction. Plausible reasons for patients not preferring extended-interval monitoring include increased anxiety and disengagement from self-management activities, both potentially related to less frequent feedback and reassurance during extended interval-monitoring. Additional research is needed to identify who is likely to benefit most from extended-interval monitoring. Anticoagulation satisfaction should be considered with clinical factors and shared-decision making when implementing extended-interval warfarin monitoring.
Volume
42
Issue
4
First Page
486
Last Page
493
Disciplines
Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences
NSUWorks Citation
Carris, Nicholas W.; Hwang, Andrew Y.; Smith, Steven M.; Taylor, James R.; Sando, Karen R.; Powell, Jason; Rosenberg, Eric I.; Zumberg, Marc S.; Gums, John G; Dietrich, Eric A; and Anderson, Katherine Vogel, "Patient Satisfaction with Extended-Interval Warfarin Monitoring" (2016). Faculty Articles. 345.
https://nsuworks.nova.edu/hpd_corx_facarticles/345
